Chi‐Pin Lee
Impact in
- Periodontics top 5%
- Oral Health Pathology and Treatment
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- RNA Research and Splicing 2
- Inflammasome and immune disorders 2
- Heat shock proteins research 1
-
- Gout, Hyperuricemia, Uric Acid 7
- Co-authors
- Ying‐Chin Ko (15 shared papers)Albert Min‐Shan Ko (9 shared papers)Srinivasan Nithiyanantham (5 shared papers)Chung‐Ming Huang (5 shared papers)Kun‐Tu Yeh (6 shared papers)Shang‐Lun Chiang (6 shared papers)Hung‐Pin Tu (4 shared papers)Hui‐Ting Hsu (5 shared papers)
In The Last Decade
Chi‐Pin Lee
22 papers receiving 352 citations
Peers
Comparison fields: 5 of 65
- Periodontics 75
- Nephrology 60
- Otorhinolaryngology 30
- Cancer Research 58
- Molecular Biology 116
Countries citing papers authored by Chi‐Pin Lee
This map shows the geographic impact of Chi‐Pin Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Pin Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Pin Lee more than expected).
Fields of papers citing papers by Chi‐Pin Lee
This network shows the impact of papers produced by Chi‐Pin Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Pin Lee. The network helps show where Chi‐Pin Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi‐Pin Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 33 | |
| 2 | 2010 | 30 | |
| 3 | 2018 | 28 | |
| 4 | 2011 | 24 | |
| 5 | 2019 | 20 | |
| 6 | 2019 | 19 | |
| 7 | 2016 | 18 | |
| 8 | 2017 | 17 | |
| 9 | 2020 | 17 | |
| 10 | 2021 | 16 | |
| 11 | 2021 | 16 | |
| 12 | 2017 | 15 | |
| 13 | 2016 | 15 | |
| 14 | 2020 | 14 | |
| 15 | 2016 | 14 | |
| 16 | 2018 | 13 | |
| 17 | 2015 | 12 | |
| 18 | 2019 | 11 | |
| 19 | 2016 | 9 | |
| 20 | 2018 | 8 |
About Chi‐Pin Lee
Chi‐Pin Lee is a scholar working on Molecular Biology, Nephrology, Periodontics, Otorhinolaryngology and Cancer Research, having authored 22 papers that have together received 354 indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (7 papers), Oral Health Pathology and Treatment (7 papers), Head and Neck Cancer Studies (4 papers), Cancer-related molecular mechanisms research (3 papers), RNA Research and Splicing (2 papers), Inflammasome and immune disorders (2 papers), Heat shock proteins research (1 paper) and Case Reports on Hematomas (1 paper). The work is most often cited by research in Periodontics (75 citations), Nephrology (60 citations), Otorhinolaryngology (30 citations), Cancer Research (58 citations) and Molecular Biology (116 citations). Chi‐Pin Lee has collaborated with scholars based in Taiwan, China and Germany. Frequent co-authors include Ying‐Chin Ko, Albert Min‐Shan Ko, Srinivasan Nithiyanantham, Chung‐Ming Huang, Kun‐Tu Yeh, Shang‐Lun Chiang, Hung‐Pin Tu, Hui‐Ting Hsu, Shu‐Jung Wang and Chien‐Hung Lee. Their work appears in journals such as Journal of Molecular Medicine, PLoS ONE, Scientific Reports, Addiction Biology and Food Science & Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.